Gavriilaki, E
Sakellari, I
Anagnostopoulos, A
Brodsky, R A
Article History
Received: 10 October 2016
Revised: 1 February 2017
Accepted: 5 February 2017
First Online: 13 March 2017
Competing interests
: RAB is a member of the Scientific Advisory Board of Achillion Pharmaceuticals, Alexion Pharmaceuticals and Apellis Pharmaceuticals. The remaining authors declare no conflict of interest.